Sponsor Pipeline

Cincinnati Eye Institute, Southwest Ohio Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
Active Trials by Phase
Phase 4
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07695298 A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal… Presumed Ocular Histoplasmosis Recruiting
Phase 2
NCT06541574 Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary… Proliferative Vitreoretinopathy Recruiting
Get alerts when Cincinnati Eye Institute, Southwest Ohio's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free